Komal Siddiqui
Overview
Explore the profile of Komal Siddiqui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shaikh K, Iqbal Y, Abdel-Maksoud M, Murad A, Badar N, Alarjani K, et al.
Am J Transl Res
. 2023 Aug;
15(7):4829-4850.
PMID: 37560204
Background: Head and neck squamous cell carcinoma (HNSC), a prevalent malignant tumor with a low survival rate, is often accompanied by ferroptosis, which is a recently-described type ofprogrammed cell death....
2.
Siddiqui K, Uqaili A, Memon S, Shah T, Naz Shaikh S, Memon A
Biomed Res Int
. 2023 Feb;
2023:5081303.
PMID: 36778054
Background: Celiac disease (CD) is an autoimmune genetic disorder in which gluten protein causes inflammation of the intestinal enterocytes. CD diagnosis in most cases is delayed or mistreated due to...
3.
Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis
Siddiqui K, Browne R, Benedict R, Jakimovski D, Weinstock-Guttman B, Zivadinov R, et al.
Mult Scler Relat Disord
. 2022 Nov;
69:104374.
PMID: 36403378
Background: Cognitive impairment (CI) is frequent in persons with multiple sclerosis (PwMS) and is linked to neurodegeneration. Cholesterol pathway biomarkers (CPB) are associated with blood-brain barrier breakdown, lesions, and neurodegeneration...
4.
Siddiqui K, Uqaili A, Rafiq M, Aqeel Bhutto M
Medicine (Baltimore)
. 2021 Mar;
100(11):e24954.
PMID: 33725967
Celiac disease (CD) is an autoimmune enteropathy triggered by ingestion of gluten present in wheat, barley, and rye. Gluten along with environmental trigger starts an inflammatory reaction which results in...
5.
Siddiqui K, Waris A, Akber H, Munir K, Mir M, Khan M, et al.
Pharm Nanotechnol
. 2017 Dec;
5(4):276-284.
PMID: 29278217
Background: Bioavailability is the segment of dose that is bioavailable for its therapeutic effect on the systemic circulation without any change in its characteristics, after administration by either route. It...